ICON-PLC UK Regulatory Announcement: ICON Reports Full-Year 2007 Revenue Growth of 38% Operating Income Growth of 45% and EPS Growth of 41% (NASDAQ:ICLR)

ICON (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2007.